The health reform key is in, but the implementation ignition just won't start.
The health reform key is in, but the implementation ignition just won’t start. The Affordable Care Act (ACA) employer mandate has been pushed to 2015, states are still heavily wagering Medicaid expansion, healthcare insurance exchanges are at risk for misappropriation, and at least one state is delaying their full entrance into the insurance marketplace. Growing hesitancy to embrace healthcare reform is due to the uncertainty these various delays create. And now that unease may only grow worse, as the ACA provision that limited the caps on out-of-pocket insurance costs will be also delayed until 2015.
The provision would limit out-of-pocket costs, including deductibles and copayments, to $6350 for individuals, and $12,700 for families. The delay on cost maximums will mean that insurers can set limits higher, or even offer no limit on costs through 2014.
A senior administration official, who spoke with the NY Times, said the delay came after many insurance companies voiced concern as to whether their data collection systems would be effective enough in administering coverage in a timely manner.
“We had to balance the interests of consumers with the concerns of health plan sponsors and carriers, which told us that their computer systems were not set up to aggregate all of a person’s out-of-pocket costs,” the official stated. “They asked for more time to comply.”
The wait is a relief for insurers and payers. “If you work for a large employer, it's a good bet that you have one insurance company for your medical benefits, like hospital and doctor's visits, and another company, like Express Scripts or CVS Caremark, which handles your prescription drugs. Employers like this setup because the insurers focus on controlling medical costs and Pharmacy Benefit Managers, or PBMs, as they're called, keep a lid on drugs,” Sarah Varney said a recent National Public Radio interview. “The problem is, often, the two companies don't talk to each other.”
Ed Kaplan, a senior vice president at the health benefit advisory company Segal Consulting, added that many experts are struggling with how to comply. The data is simply not managed efficiently between payers and providers.
However, some healthcare professionals worry what the delay will mean for those with chronic conditions. If a consumer has one plan for their healthcare, and another for their prescription benefits, they may end up paying up to $6350 for doctor’s services or hospital care, and another $6350 for prescription drugs through a PBM.
“We have wonderful new drugs, the biologics, to treat rheumatoid arthritis, but they are extremely expensive,” said Dr Patience H. White, a vice president of the Arthritis Foundation. “In the past, patients had to live in constant pain, often became disabled and had to leave their jobs. The new drugs can make a huge difference, and we were hoping that the cap on out-of-pocket costs would make them affordable. But now many patients will have to wait another year.”
Around the Web
ACA Implementation Continues to Face Challenges [AJMC]
Oregon to Delay Insurance Exchange Enrollment
Oregon to Delay Insurance Exchange Enrollment [AJMC]
Federal Officials Delay Another Health-law Provision for Employers [Los Angeles Times]
Administration Delays ObamaCare Caps on Out-of-Pocket Costs [The Hill]
A Limit on Consumer Costs Is Delayed in Health Care Law [NY Times]
Obama Delays Implementing Another Part Of Affordable Care Act [NPR]
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata
April 29th 2025Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported outcome measures (PROMs) specific to alopecia areata (AA), a common hair loss condition with substantial quality of life impacts.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More